On Invalid Date, Prothena Public Co (NASDAQ: PRTA) reported Q3 2023 earnings per share (EPS) of $0.41, up 142.27% year over year. Total Prothena Public Co earnings for the quarter were $21.91 million. In the same quarter last year, Prothena Public Co's earnings per share (EPS) was -$0.97.
As of Q4 2023, Prothena Public Co's earnings has grown year over year. Prothena Public Co's earnings in the past year totalled -$73.20 million.
What was PRTA's revenue last quarter?
On Invalid Date, Prothena Public Co (NASDAQ: PRTA) reported Q3 2023 revenue of $84.87 million up 5,494.33% year over year. In the same quarter last year, Prothena Public Co's revenue was $1.52 million.
What was PRTA's revenue growth in the past year?
As of Q4 2023, Prothena Public Co's revenue has grown 2,635.29% year over year. This is 2,524.72 percentage points higher than the US Biotechnology industry revenue growth rate of 110.58%. Prothena Public Co's revenue in the past year totalled $140.98 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.